Quadrant Capital Group’s Steris STE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $474K | Sell |
2,144
-297
| -12% | -$72.7K | 0.01% | 925 |
|
|
2025
Q4 | $619K | Buy |
2,441
+12
| +0.5% | +$3.01K | 0.02% | 806 |
|
|
2025
Q3 | $601K | Buy |
2,429
+75
| +3% | +$18K | 0.02% | 776 |
|
|
2025
Q2 | $565K | Buy |
2,354
+16
| +0.7% | +$3.73K | 0.02% | 795 |
|
|
2025
Q1 | $530K | Buy |
2,338
+1,303
| +126% | +$287K | 0.02% | 708 |
|
|
2024
Q4 | $213K | Sell |
1,035
-47
| -4% | -$10.3K | 0.01% | 648 |
|
|
2024
Q3 | $262K | Sell |
1,082
-15
| -1% | -$3.51K | 0.02% | 562 |
|
|
2024
Q2 | $241K | Sell |
1,097
-24
| -2% | -$5.21K | 0.02% | 556 |
|
|
2024
Q1 | $252K | Hold |
1,121
| – | – | 0.02% | 528 |
|
|
2023
Q4 | $246K | Sell |
1,121
-33
| -3% | -$6.98K | 0.02% | 513 |
|
|
2023
Q3 | $253K | Buy |
1,154
+46
| +4% | +$10.4K | 0.03% | 436 |
|
|
2023
Q2 | $249K | Sell |
1,108
-22
| -2% | -$4.4K | 0.02% | 437 |
|
|
2023
Q1 | $216K | Sell |
1,130
-9
| -0.8% | -$1.74K | 0.02% | 486 |
|
|
2022
Q4 | $210K | Buy |
1,139
+12
| +1% | +$2.11K | 0.02% | 456 |
|
|
2022
Q3 | $187K | Buy |
1,127
+205
| +22% | +$41.7K | 0.02% | 452 |
|
|
2022
Q2 | $190K | Buy |
922
+5
| +0.5% | +$1.13K | 0.03% | 443 |
|
|
2022
Q1 | $221K | Buy |
917
+19
| +2% | +$4.4K | 0.03% | 419 |
|
|
2021
Q4 | $219K | Buy |
898
+516
| +135% | +$118K | 0.03% | 417 |
|
|
2021
Q3 | $78K | Buy |
382
+25
| +7% | +$5.35K | 0.01% | 707 |
|
|
2021
Q2 | $74K | Buy |
357
+8
| +2% | +$1.61K | 0.01% | 706 |
|
|
2021
Q1 | $66K | Buy |
349
+9
| +3% | +$1.67K | 0.01% | 718 |
|
|
2020
Q4 | $64K | Buy |
340
+24
| +8% | +$4.48K | 0.01% | 669 |
|
|
2020
Q3 | $56K | Buy |
316
+135
| +75% | +$21.6K | 0.01% | 624 |
|
|
2020
Q2 | $28K | Sell |
181
-1,096
| -86% | -$167K | 0.01% | 938 |
|
|
2020
Q1 | $179K | Buy |
1,277
+62
| +5% | +$9.27K | 0.03% | 402 |
|
|
2019
Q4 | $183K | Buy |
1,215
+3
| +0.2% | +$440 | 0.02% | 699 |
|
|
2019
Q3 | $174K | Hold |
1,212
| – | – | 0.03% | 654 |
|
|
2019
Q2 | $178K | Buy |
1,212
+1,120
| +1,217% | +$150K | 0.03% | 624 |
|
|
2019
Q1 | $11K | Hold |
92
| – | – | ﹤0.01% | 1673 |
|
|
2018
Q4 | $8K | Hold |
92
| – | – | ﹤0.01% | 1477 |
|
|
2018
Q3 | $10K | Hold |
92
| – | – | ﹤0.01% | 1300 |
|
|
2018
Q2 | $8K | Hold |
92
| – | – | ﹤0.01% | 1388 |
|
|
2018
Q1 | $7K | Hold |
92
| – | – | ﹤0.01% | 1433 |
|
|
2017
Q4 | $7K | Hold |
92
| – | – | ﹤0.01% | 1359 |
|
|
2017
Q3 | $7K | Buy |
92
+28
| +44% | +$2.37K | ﹤0.01% | 1346 |
|
|
2017
Q2 | $5K | Hold |
64
| – | – | ﹤0.01% | 1369 |
|
|
2017
Q1 | $4K | Buy |
+64
| New | +$4.43K | ﹤0.01% | 1426 |
|
|
2016
Q4 | – | Sell |
-13
| Closed | – | – | 2068 |
|
|
2016
Q3 | $0 | Buy |
+13
| New | +$918 | ﹤0.01% | 2070 |
|
|
2016
Q1 | – | Sell |
-11
| Closed | – | – | 1971 |
|
|
2015
Q4 | $0 | Sell |
11
-9
| -45% | -$650 | ﹤0.01% | 1689 |
|
|
2015
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 1111 |
|
|
2015
Q2 | $1K | Buy |
+20
| New | +$1.35K | ﹤0.01% | 1090 |
|
Other funds holding STE
VCM
VPM
OAG
GIM
Quadrant Capital Group's STE Position: Q1 2026 in Review
Quadrant Capital Group reduced its Steris (STE) stake by 12% in Q1 2026, selling an estimated $72.7K and leaving 2,144 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #925.
Quadrant Capital Group first reported a position in STE in Q2 2015 and has held it in 41 quarters since. The position peaked at $619K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.
- Quadrant Capital Group held 2,144 shares of Steris worth $474K as of Q1 2026.
- Quadrant Capital Group sold 297 Steris shares in Q1 2026, an estimated $72.7K.
- Steris made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #925 holding.
- Quadrant Capital Group first reported a position in Steris in Q2 2015 and has held it in 41 quarters since.
- Quadrant Capital Group's Steris position peaked at $619K in Q4 2025.
- 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.